- Home
- DNTH vs BV Comparison
DNTH vs BV Comparison
Compare DNTH & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- BV
- Stock Information
- Founded
- DNTH 2015
- BV 1939
- Country
- DNTH United States
- BV United States
- Employees
- DNTH N/A
- BV N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- BV Business Services
- Sector
- DNTH Health Care
- BV Consumer Discretionary
- Exchange
- DNTH Nasdaq
- BV Nasdaq
- Market Cap
- DNTH 1.4B
- BV 1.4B
- IPO Year
- DNTH N/A
- BV 2018
- Fundamental
- Price
- DNTH $33.73
- BV $12.26
- Analyst Decision
- DNTH Strong Buy
- BV Buy
- Analyst Count
- DNTH 11
- BV 6
- Target Price
- DNTH $65.22
- BV $17.98
- AVG Volume (30 Days)
- DNTH 503.3K
- BV 701.2K
- Earning Date
- DNTH 11-05-2025
- BV 11-19-2025
- Dividend Yield
- DNTH N/A
- BV N/A
- EPS Growth
- DNTH N/A
- BV N/A
- EPS
- DNTH N/A
- BV 0.12
- Revenue
- DNTH $4,854,000.00
- BV $2,698,700,000.00
- Revenue This Year
- DNTH N/A
- BV $0.10
- Revenue Next Year
- DNTH N/A
- BV $2.09
- P/E Ratio
- DNTH N/A
- BV $101.38
- Revenue Growth
- DNTH 17.87
- BV N/A
- 52 Week Low
- DNTH $13.37
- BV $11.81
- 52 Week High
- DNTH $40.16
- BV $18.89
- Technical
- Relative Strength Index (RSI)
- DNTH 47.36
- BV 34.07
- Support Level
- DNTH $32.28
- BV $12.10
- Resistance Level
- DNTH $35.40
- BV $13.37
- Average True Range (ATR)
- DNTH 1.62
- BV 0.30
- MACD
- DNTH -0.20
- BV -0.05
- Stochastic Oscillator
- DNTH 27.78
- BV 16.54
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.